Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

New clinical results for Cypros' CPC-111

Feb. 28, 1997

Positive results reported for VasoCare in MI

Feb. 27, 1997

Harvard College discloses vascular injury-associated gene

Feb. 27, 1997

Cytel and Sumitomo expand agreement

Feb. 26, 1997

Bayer and Zeneca to comarket Ca antagonist

Feb. 26, 1997

Adenosine antagonists claimed by Fujisawa

Feb. 26, 1997

Unexpected phase I results reported for DuP-532

Feb. 25, 1997

Deltibant in SIRS

Feb. 21, 1997

Cylexin enters clinical trials in newborns

Feb. 21, 1997

Novel vasopressin antagonists from Fujisawa

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...